India’s drug regulator grants Gilead Sciences marketing authorisation for remdesivir

Hindu

01 Jun 2020 0 shares 1 views

Hindu

Published 01 Jun 2020

Gilead Sciences had on May 29 applied for marketing authorisation for remdesivir in India.

India crosses 4-lakh COVID-19 cases mark

Eight days after recording three lakh COVID-19 cases, India went past the four lakh-mark on Sunday with the biggest single-day..

Mid-Day 22 Jun 2020

India's drug regulator has granted US pharma giant Gilead Sciences marketing authorisation for its anti-viral drug remdesivir for..

IndiaTimes 02 Jun 2020